Gene · 28935
Papers1,911
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,911
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Robust immune response to SARS-CoV-2 mRNA vaccines may exacerbate the clinical symptoms of A20 haploinsufficiency. | Pediatr Int | 2025 | 40415737 | PubTator, text mining | PubMed |
| CYLD-TRAF6 interaction promotes ADP-heptose-induced NF-κB signaling in H. pylori infection. | EMBO Rep | 2025 | 40404856 | PubTator, text mining | PubMed |
| Traffic-related diesel pollution particles impair the lysosomal functions of human iPSC-derived microglia. | Environ Int | 2025 | 40349663 | PubTator, text mining | PubMed |
Association of serum A20 levels with stroke-associated pneumonia, early neurological deterioration, and poor neurological prognosis following acute supratentorial intracerebral hemorrhage: a prospective cohort study. | Front Neurol | 2025 | 40343186 | PubTator, text mining | PubMed |
| Downregulation of A20 Expression Related to T Cells by Staphylococcal Enterotoxin A Treatment. | Bull Exp Biol Med | 2025 | 40299129 | PubTator, text mining | PubMed |
| Interference Mitigation Using UNet for Integrated Sensing and Communicating Vehicle Networks via Delay-Doppler Sounding Reference Signal Approach. | Sensors (Basel) | 2025 | 40293069 | PubTator, text mining | PubMed |
| Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv. | J Transl Med | 2025 | 40241132 | PubTator, text mining | PubMed |
| The Role of A20 in Cancer: Friend or Foe? | Cells | 2025 | 40214497 | PubTator, text mining | PubMed |
| Correction: Differential expression of the ubiquitin-editing enzyme A20 in gastric biopsies indicates the severity of disease. | Histochem Cell Biol | 2025 | 40198379 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of Schiff-Base Isoxazole hybrids: Exploring novel antimicrobial agents. | Bioorg Chem | 2025 | 40184667 | PubTator, text mining | PubMed |
| Author Correction: A20 controls intestinal homeostasis through cell-specific activities. | Nat Commun | 2025 | 40164618 | PubTator, text mining | PubMed |
| Two Birds with One Stone: Fe-DNA nanospheres produced via coordination-propelled self-assembly with excellent peroxidase-like property for versatile ratiometric fluorescent assay and cellular imaging. | Biosens Bioelectron | 2025 | 40163949 | PubTator, text mining | PubMed |
| TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment. | J Clin Invest | 2025 | 40111422 | PubTator, text mining | PubMed |
| Scoping review protocol: The chrononutrition factors in association with glycemic outcomes in adult population. | PLoS One | 2025 | 39951411 | PubTator, text mining | PubMed |
| Rational Design of Natural Xanthones Against Gram-negative Bacteria. | Adv Sci (Weinh) | 2025 | 39888292 | PubTator, text mining | PubMed |
| A20 as a Potential Therapeutic Target for COVID-19. | Immun Inflamm Dis | 2025 | 39853876 | PubTator, text mining | PubMed |
| Multilayered Nanocarriers as a New Strategy for Delivering Drugs with Protective and Anti-inflammatory Potential: Studies in Hippocampal Organotypic Cultures Subjected to Experimental Ischemia. | Mol Neurobiol | 2025 | 39786699 | PubTator, text mining | PubMed |
| Correction: NF-κB regulated expression of A20 controls IKK dependent repression of RIPK1 induced cell death in activated T cells. | Cell Death Differ | 2025 | 39627362 | PubTator, text mining | PubMed |
| Ubiquitin-Proteasome System in Periodontitis: Mechanisms and Clinical Implications. | Cell Prolif | 2025 | 39626954 | PubTator, text mining | PubMed |
| Efficiency of dry versus wet Er,Cr:YSGG laser debonding of lithium disilicate veneers using different power outputs. | J Prosthet Dent | 2025 | 39353756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28935/papers?page=4